TD Cowen lowered the firm’s price target on Delek US to $25 from $27 and keeps a Hold rating on the shares. The firm said the company sounded confident about future prospects of its value unlock process, though it provided limited incremental details and is yet to deliver any restructuring one and a half years into the process.